Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 25, 2015 12:29 AM ET

Pharmaceuticals

Company Overview of Allergan Inc.

Executive Profile

David J. Endicott

President of Hospira Medical Devices, Hospira Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
49$6,931,528
As of Fiscal Year 2014

Background

Mr. David J. Endicott has been the President of Hospira Medical Devices at Hospira Inc. since March 10, 2014. Mr. Endicott served as a Corporate Vice President and President of Allergan Medical, Asia Pacific and Latin America at Allergan Inc. since April 2011. He served as Corporate Vice President and President of Allergan Medical at Allergan, Inc. since August 2010. He served as Corporate Vice President and President of Europe, Africa and Middle East at Allergan, Inc. ...

Corporate Headquarters

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships

2012-Present
Director and Member of Nominating/Corporate Governance Committee

Education

MBA
University of Southern California
Unknown/Other Education
Harvard Business School
Bachelor's Degree
Whitman College

Other Affiliations

Annual Compensation

Salary$512,500
Total Annual Compensation$512,500

Stocks Options

Restricted Stock Awards$4,166,667
All Other Compensation$373,532
Unexercisable Options$72,971
Unexercisable Options Value$1,330,991
Total Value of Options$1,330,991
Total Number of Options$72,971

Total Compensation

Total Annual Cash Compensation$1,931,532
Total Short Term Compensation$512,500
Other Long Term Compensation$4,540,199
Total Calculated Compensation$6,931,528
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Scott D. Farmer Chief Executive Officer, Director and Member of Executive Committee
Cintas Corporation
$816.0K
David C. Dvorak Chief Executive Officer, President and Director
Zimmer Holdings, Inc.
$934.9K
Osamu Nagayama Chairman and Chief Executive Officer
Chugai Pharmaceutical Co. Ltd.
$266.0M
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Mark Christopher Trudeau Chief Executive Officer, President, Director and Member of Portfolio Committee
Mallinckrodt public limited company
$905.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Allergan Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.